NCT00043888 - Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions

HIV Infections

Interventions

DRUG

fosamprenavir

DRUG

COMBIVIR

DRUG

ritonavir

DRUG

TRIZIVIR

Trial Locations (18)

19107

GSK Clinical Trials Call Center, Philadelphia

20036

GSK Clinical Trials Call Center, Washington D.C.

27858

GSK Clinical Trials Call Center, Greenville

30339

GSK Clinical Trials Call Center, Atlanta

32701

GSK Clinical Trials Call Center, Altamonte Springs

33308

GSK Clinical Trials Call Center, Fort Lauderdale

33316

GSK Clinical Trials Call Center, Fort Lauderdale

33334

GSK Clinical Trials Call Center, Fort Lauderdale

69437

GSK Clinical Trials Call Center, Lyon

72205

GSK Clinical Trials Call Center, Little Rock

75475

GSK Clinical Trials Call Center, Paris

75679

GSK Clinical Trials Call Center, Paris

80220

GSK Clinical Trials Call Center, Denver

90813

GSK Clinical Trials Call Center, Long Beach

92101

GSK Clinical Trials Call Center, San Diego

92663

GSK Clinical Trials Call Center, Newport Beach

SE5 9RS

GSK Clinical Trials Call Center, London

M8 6RL

GSK Clinical Trials Call Center, Manchester